This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Oncolytics Biotech (developing oncolytic virsues as cancer therapies) netted $Cdn3.45mm ($2.8mm) through a follow-on public offering of 2.5mm common shares at $Cdn1.50 each. Investors also received three-year warrants to purchase 2.5mm shares at $Cdn1.80 apiece.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?